Total Payments
$41,494
2024 Payments
$1,017
Companies
54
Transactions
513
Medicare Patients
11,293
Medicare Billing
$2.1M
Payment Breakdown by Category
Consulting$21,800 (52.5%)
Food & Beverage$10,817 (26.1%)
Other$8,417 (20.3%)
Education$459.59 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,800 | 6 | 52.5% |
| Food and Beverage | $10,817 | 492 | 26.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,400 | 2 | 20.2% |
| Education | $459.59 | 12 | 1.1% |
| Entertainment | $17.48 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $22,461 | 27 | $0 (2019) |
| Bard Peripheral Vascular, Inc. | $9,832 | 31 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $1,217 | 84 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,165 | 82 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $471.82 | 19 | $0 (2024) |
| Amgen Inc. | $466.69 | 21 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $428.42 | 31 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $422.86 | 11 | $0 (2023) |
| Boston Scientific Corporation | $380.55 | 15 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $352.93 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,017 | 39 | Kestra Medical Technology Services, Inc. ($219.25) |
| 2023 | $1,174 | 51 | Impulse Dynamics (USA) Inc. ($262.09) |
| 2022 | $1,532 | 77 | Actelion Pharmaceuticals US, Inc. ($331.82) |
| 2021 | $1,830 | 91 | Bard Peripheral Vascular, Inc. ($517.47) |
| 2020 | $5,714 | 45 | Bard Peripheral Vascular, Inc. ($4,752) |
| 2019 | $5,448 | 61 | BARD PERIPHERAL VASCULAR, INC. ($4,544) |
| 2018 | $875.33 | 55 | Lundbeck LLC ($128.50) |
| 2017 | $23,903 | 94 | Philips Electronics North America Corporation ($22,206) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Structural Heart | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $44.52 | General |
| Category: Cardiology | ||||||
| 08/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $47.79 | General |
| Category: Cardiology | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.80 | General |
| 06/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $53.58 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,439 | 7,130 | $1.4M | $415,245 |
| 2022 | 25 | 2,746 | 9,273 | $1.6M | $476,151 |
| 2021 | 33 | 2,786 | 8,619 | $1.5M | $457,422 |
| 2020 | 41 | 3,322 | 13,605 | $2.5M | $771,238 |
Total Patients
11,293
Total Services
38,627
Medicare Billing
$2.1M
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 564 | 1,414 | $452,480 | $130,917 | 28.9% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 71 | 71 | $267,173 | $83,834 | 31.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 71 | 142 | $141,716 | $45,417 | 32.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 157 | 157 | $77,244 | $23,158 | 30.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 105 | 420 | $62,160 | $18,394 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 294 | $66,738 | $17,090 | 25.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 51 | 51 | $56,355 | $16,867 | 29.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Office | 2023 | 18 | 18 | $48,366 | $14,460 | 29.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 79 | 80 | $37,360 | $11,662 | 31.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 51 | 102 | $28,764 | $9,207 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $32,916 | $8,367 | 25.4% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 74 | 87 | $25,404 | $7,678 | 30.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 126 | 126 | $22,176 | $6,602 | 29.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 484 | 625 | $22,500 | $6,383 | 28.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 22 | 22 | $10,472 | $3,061 | 29.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 15 | 16 | $9,616 | $2,984 | 31.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 35 | 41 | $5,166 | $1,609 | 31.2% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 20 | 21 | $5,103 | $1,606 | 31.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 49 | $6,958 | $1,402 | 20.1% |
| 76937 | Ultrasonic guidance for blood vessel access | Office | 2023 | 34 | 42 | $4,116 | $1,309 | 31.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 13 | $3,861 | $1,208 | 31.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 16 | 16 | $2,960 | $582.12 | 19.7% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 17 | 58 | $1,566 | $504.78 | 32.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 20 | 21 | $1,323 | $410.13 | 31.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 33 | 3,150 | $3,150 | $365.63 | 11.6% |
About Dr. Karan Reddy, M.D
Dr. Karan Reddy, M.D is a Cardiovascular Disease healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659375012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karan Reddy, M.D has received a total of $41,494 in payments from pharmaceutical and medical device companies, with $1,017 received in 2024. These payments were reported across 513 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($21,800).
As a Medicare-enrolled provider, Reddy has provided services to 11,293 Medicare beneficiaries, totaling 38,627 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Winter Park, FL
- Active Since 06/13/2005
- Last Updated 07/20/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1659375012
Products in Payments
- PV.035 (Device) $21,800
- VENOVO (Device) $4,930
- XARELTO (Drug) $1,214
- ENTRESTO (Drug) $902.18
- IGT_D Peripheral (Device) $506.53
- Rotarex (Device) $451.79
- ELIQUIS (Drug) $414.48
- Repatha (Biological) $394.13
- JARDIANCE (Drug) $374.27
- Assure WCD (Device) $330.93
- LifeVest (Device) $291.68
- VERQUVO (Drug) $272.72
- OPSUMIT (Drug) $265.67
- Vascepa (Drug) $265.25
- LEQVIO (Drug) $262.51
- OPTIMIZER (Device) $262.09
- NORTHERA (Drug) $229.24
- Adempas (Drug) $194.79
- CoreValve Evolut (Device) $169.91
- Verquvo (Drug) $158.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Winter Park
Dr. Usman Siddiqui, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Sandeep Bajaj, M.d, M.D
Cardiovascular Disease — Payments: $15,332
Cardiovascular Disease $15,332
Dr. Milan Kothari, M.d, M.D
Cardiovascular Disease — Payments: $13,362
Cardiovascular Disease $13,362
Barton Sickinger, Do Facc, DO FACC
Cardiovascular Disease — Payments: $12,968
Cardiovascular Disease $12,968
Dr. Kunal Teli, M.d, M.D
Cardiovascular Disease — Payments: $7,814
Cardiovascular Disease $7,814
Dr. Harish Patil, M.d, M.D
Cardiovascular Disease — Payments: $5,478
Cardiovascular Disease $5,478